Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c, Beats on Revenues

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.91, $0.02 better than the analyst estimate of $1.89. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $1.98 billion.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
• Broadcom (AVGO) Tops Q2 EPS by 5c, Offers Guidance